Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
1.
Am J Public Health ; 91(10): 1686-93, 2001 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11574336

RESUMEN

OBJECTIVES: This study reports on Eat for Life, a multicomponent intervention to increase fruit and vegetable consumption among African Americans that was delivered through Black churches. METHODS: Fourteen churches were randomly assigned to 3 treatment conditions: (1) comparison, (2) self-help intervention with 1 telephone cue call, and (3) self-help with 1 cue call and 3 counseling calls. The telephone counseling in group 3 was based on motivational interviewing. The primary outcome, assessed at baseline and 1-year follow-up, was fruit and vegetable intake as assessed by 3 food frequency questionnaires. RESULTS: Change in fruit and vegetable intake was significantly greater in the motivational interviewing group than in the comparison and self-help groups. The net difference between the motivational interviewing and comparison groups was 1.38, 1.03, and 1.21 servings of fruits and vegetables per day for the 2-item, 7-item, and 36-item food frequency questionnaires, respectively. The net difference between the motivational interviewing and self-help groups was 1.14, 1.10, and 0.97 servings for the 2-item, 7-item, and 36-item food frequency questionnaires, respectively. CONCLUSIONS: Motivational interviewing appears to be a promising strategy for modifying dietary behavior, and Black churches are an excellent setting to implement and evaluate health promotion programs.


Asunto(s)
Negro o Afroamericano/psicología , Dieta/psicología , Frutas , Entrevista Psicológica , Motivación , Religión y Psicología , Verduras , Consejo , Femenino , Frutas/uso terapéutico , Humanos , Masculino , Evaluación de Resultado en la Atención de Salud , Comunicación Persuasiva , Fitoterapia , Verduras/uso terapéutico
2.
J Hum Nutr Diet ; 14(4): 307-18, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11493389

RESUMEN

AIM: To collate information on current British dietetic practice in the area of diet in secondary prevention of myocardial infarction, and to compare this with best evidence. METHODS: A questionnaire was sent to all Chief Dietitians, to be completed by the whole department, asking about current dietary advice and practice, referrals and written dietary information for people following myocardial infarction. RESULTS: Fifty-seven per cent of questionnaires were returned. Dietary fat advice was prioritized by 84% of departments, fruit and vegetables by 49%, oily fish by 45% and fibre by 28%. Most dietitians (81%) felt that this advice would protect from further cardiovascular disease. Percentages of post-myocardial infarction patients given advice by a dietitian varied (median 60%), reasons for non-referral included patients having normal lipids or weight. More were given dietary advice by another health professional (median 90%); however, most dietitians were unsure about the quality of this advice. Diet sheets were felt to reflect advice priorities, but where sheets were sent they were much less likely than departments to prioritize oily fish or fruit and vegetable advice. CONCLUSION: Dietetic practice for people following myocardial infarction is out of line with current best evidence. Almost half of departments correctly prioritize oily fish advice, but often only see patients with raised lipids or weight. This is not the most effective strategy for preventing deaths.


Asunto(s)
Dieta , Dietética , Guías como Asunto/normas , Infarto del Miocardio/dietoterapia , Infarto del Miocardio/prevención & control , Encuestas sobre Dietas , Fibras de la Dieta/uso terapéutico , Aceites de Pescado/uso terapéutico , Frutas/uso terapéutico , Humanos , Hiperlipidemias , Obesidad , Fitoterapia , Derivación y Consulta , Encuestas y Cuestionarios , Reino Unido , Verduras/uso terapéutico
3.
J Assoc Physicians India ; 49: 327-31, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11291971

RESUMEN

OBJECTIVE: To determine the efficacy of various antioxidant vitamins and a major dietary source of antioxidants (fruits) we performed a randomized controlled trial. METHODS: 175 successive patients with coronary heart disease (CHD) presenting to our centre were recruited and using a Latin-square design divided into five groups of 35 each. The groups were matched for age, lifestyle and dietary variables, clinical diagnosis and drug treatment status. None of the patients was on lipid-lowering drugs. Supplemental vitamins were stopped for one month before study began and American Heart Association Step II dietary advice was given to all. At baseline, total cholesterol, triglycerides, HDL and LDL cholesterol and lipid peroxide measured as thiobarbaturic acid reactive substances (TBARS) were determined. Group I received placebo capsules; Group II vitamin E 400 units/day; Group III vitamin C 1,000 mg; Group IV vitamin A 25,000 IU; Group V received 400 gm of fruit daily. Lipids and lipid peroxide levels were determined at 30 days follow-up. RESULTS: Response rate in various groups varied form 86% to 91%. No significant changes in total, HDL, LDL cholesterol and triglyceride levels were seen in Groups I, II, III and IV (paired t-test p > 0.05). In Group V there was a significant decrease in total cholesterol (-7.8 +/- 11.1%), and LDL cholesterol (-11.2 +/- 25.4%) and increase in HDL cholesterol (+12.9 +/- 20.1%) (paired t-test p < 0.01). Lipid peroxide levels decreased significantly in all the treatment groups (p < 0.01). This decrease was the highest in Group II (vitamin E; -36.4 +/- 17.7%) as compared to Group III (vitamin C -19.8 -/+ 10.8%); Group IV (vitamin A -5.4 +/- 17%) and Group V (fruits -13.1 +/- 12.0%). CONCLUSIONS: All the antioxidant vitamins and fruits significantly decrease lipid peroxide levels and oxidant load in CHD patients. However, fruits are the best choice as they also favourably modify the lipid profile.


Asunto(s)
Antioxidantes/uso terapéutico , Enfermedad Coronaria/terapia , Frutas/uso terapéutico , Fitoterapia , Vitaminas/uso terapéutico , Ácido Ascórbico/uso terapéutico , Colesterol/sangre , Enfermedad Coronaria/sangre , Suplementos Dietéticos , Femenino , Humanos , Peróxidos Lipídicos/sangre , Masculino , Persona de Mediana Edad , Resultado del Tratamiento , Triglicéridos/sangre , Vitamina A/uso terapéutico , Vitamina E/uso terapéutico
5.
Free Radic Biol Med ; 30(6): 583-94, 2001 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-11295356

RESUMEN

It is rare to see a day pass in which we are not told through some popular medium that the population is becoming older. Along with this information comes the "new" revelation that as we enter the next millennium there will be increases in age-associated diseases (e.g., cancer, cardiovascular disease) including the most devastating of these, which involve the nervous system (e.g., Alzheimer's disease [AD] and Parkinson's disease [PD]). It is estimated that within the next 50 years approximately 30% of the population will be aged 65 years or older. Of those between 75 and 84 years of age, 6 million will exhibit some form of AD symptoms, and of those older than 85 years, over 12 million will have some form of dementia associated with AD. What appears more ominous is that many cognitive changes occur even in the absence of specific age-related neurodegenerative diseases. Common components thought to contribute to the manifestation of these disorders and normal age-related declines in brain performance are increased susceptibility to long-term effects of oxidative stress (OS) and inflammatory insults. Unless some means is found to reduce these age-related decrements in neuronal function, health care costs will continue to rise exponentially. Thus, it is extremely important to explore methods to retard or reverse age-related neuronal deficits as well as their subsequent, behavioral manifestations. Fortunately, the growth of knowledge in the biochemistry of cell viability has opened new avenues of research focused at identifying new therapeutic agents that could potentially disrupt the perpetual cycle of events involved in the decrements associated with these detrimental processes. In this regard, a new role in which certain dietary components may play important roles in alleviating certain disorders are beginning to receive increased attention, in particular those involving phytochemicals found in fruits and vegetables.


Asunto(s)
Flavonoides , Enfermedades del Sistema Nervioso/tratamiento farmacológico , Enfermedad de Alzheimer/tratamiento farmacológico , Enfermedad de Alzheimer/fisiopatología , Animales , Ácido Ascórbico/uso terapéutico , Capsicum/uso terapéutico , Carotenoides/uso terapéutico , Frutas/química , Frutas/uso terapéutico , Ajo/química , Ajo/uso terapéutico , Ginkgo biloba/uso terapéutico , Humanos , Enfermedades del Sistema Nervioso/fisiopatología , Panax/uso terapéutico , Enfermedad de Parkinson/tratamiento farmacológico , Enfermedad de Parkinson/fisiopatología , Fenoles/uso terapéutico , Fitoterapia , Plantas Medicinales , Polímeros/uso terapéutico , Polifenoles , Té/uso terapéutico , Vitamina E/uso terapéutico
6.
J Ethnopharmacol ; 73(1-2): 71-9, 2000 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11025141

RESUMEN

The aqueous juice of bittergourd fruit (BF) (Momordica charantia L.) of the family Cucurbitaceae has been shown to possess hypoglycemic activity. However, the mechanism of its action is not known. Hence in vitro and in vivo experiments were carried out to study the role of BF juice on the diabetic status. The activity of BF juice was tested on STZ treated RIN cells and isolated islets in vitro. It was found that feeding with BF juice caused reduction in STZ-induced hyperglycemia in mice. It markedly reduced the STZ-induced lipid peroxidation in pancreas of mice, RIN cells and islets. Further it also reduced the STZ-induced apoptosis in RIN cells indicating the mode of protection of BF juice on RIN cells, islets and pancreatic beta-cells. Present study thus confirms hypoglycemic effect of BF juice and provides sufficient documentation to define its role and action for its potential and promising use in treating diabetes.


Asunto(s)
Diabetes Mellitus Experimental/tratamiento farmacológico , Frutas/uso terapéutico , Hipoglucemiantes/uso terapéutico , Islotes Pancreáticos/efectos de los fármacos , Peroxidación de Lípido/efectos de los fármacos , Fitoterapia , Extractos Vegetales/uso terapéutico , Análisis de Varianza , Animales , Apoptosis/efectos de los fármacos , Bebidas , Células Cultivadas , Citometría de Flujo , Hiperglucemia/tratamiento farmacológico , Hipoglucemiantes/aislamiento & purificación , Hipoglucemiantes/farmacología , Masculino , Ratones , Ratones Endogámicos BALB C , Extractos Vegetales/farmacología
7.
Cancer Epidemiol Biomarkers Prev ; 9(8): 795-804, 2000 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-10952096

RESUMEN

The evidence for a protective effect of vegetables, fruits, and legumes against prostate cancer is weak and inconsistent. We examined the relationship of these food groups and their constituent foods to prostate cancer risk in a multicenter case-control study of African-American, white, Japanese, and Chinese men. Cases (n = 1619) with histologically confirmed prostate cancer were identified through the population-based tumor registries of Hawaii, San Francisco, and Los Angeles in the United States and British Columbia and Ontario in Canada. Controls (n = 1618) were frequency-matched to cases on ethnicity, age, and region of residence of the case, in a ratio of approximately 1:1. Dietary and other information was collected by in-person home interview; a blood sample was obtained from control subjects for prostate-specific antigen determination. Odds ratios (OR) were estimated using logistic regression, adjusting for age, geographic location, education, calories, and when indicated, ethnicity. Intake of legumes (whether total legumes, soyfoods specifically, or other legumes) was inversely related to prostate cancer (OR for highest relative to lowest quintile for total legumes = 0.62; P for trend = 0.0002); results were similar when restricted to prostate-specific antigen-normal controls or to advanced cases. Intakes of yellow-orange and cruciferous vegetables were also inversely related to prostate cancer, especially for advanced cases, among whom the highest quintile OR for yellow-orange vegetables = 0.67 (P for trend = 0.01) and the highest quintile OR for cruciferous vegetables = 0.61 (P for trend = 0.006). Intake of tomatoes and of fruits was not related to risk. Findings were generally consistent across ethnic groups. These results suggest that legumes (not limited to soy products) and certain categories of vegetables may protect against prostate cancer.


Asunto(s)
Anticarcinógenos/uso terapéutico , Conducta Alimentaria/etnología , Fitoterapia , Neoplasias de la Próstata/etnología , Neoplasias de la Próstata/prevención & control , Verduras/uso terapéutico , Anciano , Pueblo Asiatico , Población Negra , Colombia Británica/epidemiología , California/epidemiología , Estudios de Casos y Controles , Encuestas sobre Dietas , Fabaceae/uso terapéutico , Frutas/uso terapéutico , Hawaii/epidemiología , Humanos , Modelos Logísticos , Masculino , Oportunidad Relativa , Ontario/epidemiología , Plantas Medicinales , Antígeno Prostático Específico/sangre , Población Blanca
8.
J R Soc Promot Health ; 120(1): 52-3, 2000 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10918785

RESUMEN

With generalised increased use of antibiotics there has been the accompanying development of antibiotic resistance. It has been suggested that the therapy of uncomplicated cystitis is one area in which it is possible to reduce the usage of such compounds. Many women have long drunk cranberry juice--and it has become an 'old-wives' tale in the treatment of this infection. Perhaps it is now time for science to investigate further the benefits of the humble cranberry.


Asunto(s)
Cistitis/prevención & control , Frutas/uso terapéutico , Fitoterapia , Plantas Medicinales/uso terapéutico , Bebidas , Cistitis/fisiopatología , Femenino , Humanos
10.
Cochrane Database Syst Rev ; (2): CD001321, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-10796774

RESUMEN

BACKGROUND: Cranberries (particularly in the form of cranberry juice) have been used widely for several decades for the prevention and treatment of urinary tract infections. The aim of this review is to assess the effectiveness of cranberries in preventing such infections. OBJECTIVES: To assess the effectiveness of cranberry juice and other cranberry products in preventing urinary tract infections in susceptible populations. SEARCH STRATEGY: Electronic databases and the Internet were searched using English and non English language terms; companies involved with the promotion and distribution of cranberry preparations were contacted; reference lists of review articles and relevant trials were searched. SELECTION CRITERIA: All randomised or quasi randomised controlled trials of cranberry juice/products for the prevention of urinary tract infections in susceptible populations. Trials of men, women or children were included. DATA COLLECTION AND ANALYSIS: Reviewers RJ and LM independently assessed and extracted information using specially designed data extraction forms. For each included trial, information was collected on methods of the trial, participants, interventions and outcomes. We were unable to perform statistical analysis due to the nature of the data available for review. MAIN RESULTS: Four trials met the inclusion criteria (three cross-over, one parallel group). Three compared the effectiveness of cranberry juice versus placebo juice or water and one compared the effectiveness of cranberry capsules versus placebo. Two further trials were excluded. The outcomes of interest were number of urinary tract infections in each group (symptomatic and asymptomatic), side effects and adherence to therapy. Data from three out of the four trials indicated that cranberries were effective for at least one of the outcomes of interest. The quality of the four included trials was poor, however, and thus the reliability of the results must be questionable. REVIEWER'S CONCLUSIONS: The small number of poor quality trials gives no reliable evidence of the effectiveness of cranberry juice and other cranberry products. The large number of dropouts/withdrawals from the trials indicates that cranberry juice may not be acceptable over long periods of time. Other cranberry products such as cranberry capsules may be more acceptable. On the basis of the available evidence, cranberry juice cannot be recommended for the prevention of urinary tract infections in susceptible populations. Further properly designed trials with relevant outcomes are needed.


Asunto(s)
Frutas/uso terapéutico , Fitoterapia , Infecciones Urinarias/prevención & control , Bebidas , Humanos
11.
Cochrane Database Syst Rev ; (2): CD001322, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-10796775

RESUMEN

BACKGROUND: Cranberries (particularly in the form of cranberry juice) have been used widely for several decades for the prevention and treatment of urinary tract infections. The aim of this review is to assess the effectiveness of cranberries in treating such infections. OBJECTIVES: To assess the effectiveness of cranberries for the treatment of urinary tract infections. SEARCH STRATEGY: The search strategy developed by the Cochrane Renal Group was used. Also, companies involved with the promotion and distribution of cranberry preparations were contacted; electronic databases and the Internet were searched using English and non English language terms; reference lists of review articles and relevant trials were also searched. SELECTION CRITERIA: All randomised or quasi randomised controlled trials of cranberry juice or cranberry products for the treatment of urinary tract infections. Trials of men, women or children were included. DATA COLLECTION AND ANALYSIS: Titles and abstracts of studies that were potentially relevant to the review were screened by one reviewer, RJ, who discarded studies that were clearly ineligible but aimed to be overly inclusive rather than risk losing relevant studies. Reviewers RJ and LM independently assessed whether the studies met the inclusion criteria. Further information was sought from the authors where papers contained insufficient information to make a decision about eligibility. MAIN RESULTS: No trials were found which fulfilled all of the inclusion criteria. Two trials were excluded because they did not have any relevant outcomes. REVIEWER'S CONCLUSIONS: After a thorough search, no randomised trials which assessed the effectiveness of cranberry juice for the treatment of urinary tract infections were found. Therefore, at the present time, there is no good quality evidence to suggest that it is effective for the treatment of urinary tract infections. Well-designed parallel group, double blind trials comparing cranberry juice and other cranberry products versus placebo to assess the effectiveness of cranberry juice in treating urinary tract infections are needed. Outcomes should include reduction in symptoms, sterilisation of the urine, side effects and adherence to therapy. Dosage (amount and concentration) and duration of therapy should also be assessed. Consumers and clinicians will welcome the evidence from these trials.


Asunto(s)
Frutas/uso terapéutico , Fitoterapia , Infecciones Urinarias/terapia , Bebidas , Humanos
12.
West Indian Med J ; 49(1): 27-31, 2000 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10786447

RESUMEN

The experiments reported in this study constitute a preliminary investigation into the possible hypotensive effect of the Jamaican Cho-Cho (Sechium edule). Experiments were conducted in a random and blind fashion on two sub species of Sechium edule. Both the pulp and the peel were examined for hypotensive activity. Water-soluble extracts were prepared from these components of the fruit and injected into anaesthetised rats. Various cardiovascular parameters were measured including heart rate, mean arterial pressure (MAP) and several ECG intervals. We report that all extracts tested produced a fall in blood pressure with little change in ECG intervals. Extract B produced the least change in heart rate with a fall in MAP of approximately 23 mmHg. Changes in heart rate with all extracts appeared to be minimal as an ED25 value could only be determined for extract A, and ED10 values could not be evaluated for extracts C and D. The mechanism(s) by which these extracts produce their hypotensive effects could not be determined in these preliminary experiments. However, it appears not to involve direct effects on cardiac tissue. This conclusion is based on the finding that it took a minimum of 10 to 15 seconds for the hypotensive action to manifest post bolus. Future experiments will be aimed at delineating the mechanism(s) involved in decreasing MAP.


Asunto(s)
Antihipertensivos/uso terapéutico , Frutas/uso terapéutico , Hipertensión/tratamiento farmacológico , Fitoterapia , Extractos Vegetales/uso terapéutico , Algoritmos , Animales , Presión Sanguínea/efectos de los fármacos , Método Doble Ciego , Frecuencia Cardíaca/efectos de los fármacos , Extractos Vegetales/farmacología , Distribución Aleatoria , Ratas
13.
West Indian Med J ; 49(1): 32-3, 2000 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10786448

RESUMEN

The objective of the study was to determine the prevalence of the use of the fruit (papaya) of Carica papaya as topical ulcer dressings by registered nurses in the Spanish Town Hospital (STH), Kingston Public Hospital (KPH) and the University Hospital of the West Indies (UHWI), Jamaica. A ten-item pretested self-administered questionnaire was distributed to 285 randomly selected registered nurses at the UHWI, KPH and STH. There was a 72% response rate. The prevalence of topical papaya use among the respondents was 75%. Comments from the users of papaya suggested that topical application of the unripe fruit promoted desloughing, granulation and healing and reduced odour in chronic skin ulcers. It was cost effective. Papaya was considered to be more effective than other topical applications in the treatment of chronic ulcers. There was some difficulty in preparation of the fruit and occasionally a sensation of burning was reported by the patients. There was concern about the use of a non-sterile, non-standardised procedure but there were no reports of wound infection from its use. Papaya is widely used by nurses as a form of dressing for chronic ulcers and there is need for standardisation of its preparation and application.


Asunto(s)
Frutas/uso terapéutico , Fitoterapia , Úlcera Cutánea/terapia , Administración Tópica , Encuestas de Atención de la Salud , Humanos , Jamaica , Distribución Aleatoria , Úlcera Cutánea/clasificación , Encuestas y Cuestionarios
15.
Bol. méd. Hosp. Infant. Méx ; 57(1): 20-25, ene. 2000. tab
Artículo en Español | LILACS | ID: lil-280371

RESUMEN

Introducción. El sabor salado del suero oral (SO) puede limitar su uso. Objetivo: conocer la preferencia por varios sabores de frutas del SO: manzana, limón, naranja, piña o lima-limón y evaluar su eficacia para rehidratar niños con diarrea. Material y métodos. Cincuenta madres escogieron libremente el sabor. Posteriormente se distribuyeron al azar en 2 grupos, 230 niños deshidratados por diarrea, rehidratados con SO de sabor salado (SO) o con SO con sabor a diferentes frutas (SOF).Resultados. La preferencia de sabor fue: manzana 68 por ciento, limón 14 por ciento, piña 8 por ciento, naranja 8 por ciento, sin sabor 2 por ciento y lima-limón 0 por ciento. En el grupo SO y SOF fueron semejantes: la edad de los niños (10.5 ñ 8.2 y 11.1 ñ 7.2 meses), el porcentaje de deshidratación (3.9 ñ 2.6 y 4.2 ñ 2.4) y de sexo masculino (62 y 54 por ciento), respectivamente; al igual que la evolución con el tratamiento: ingesta de 21.8 ñ 5.6 y 20.9 ñ 5.1 mL/kg/hora, tiempo de hidratación 5.1 ñ 2.7 y 4.9 ñ 2.3 horas; gasto fecal 10.5 ñ 8.2 y 9.3 ñ 8.2 g/kg/hora, proporción de pacientes con vómitos 28 y 34 por ciento, respectivamente. Con el sabor naranja se observó la mayor proporción de vómitos (53 por ciento). En el grupo SO se observaron 15 fracasos (13 por ciento), 14 por gasto fecal alto y 1 por vómito persistente; en el grupo SOF, hubieron 13 fracasos (11.3 por ciento) 12 por gasto fecal alto y 1 por vómito persistente, aunque finalmente todos se hidrataron mediante el uso de atole de arroz o de gastroclisis. Conclusión. El SOF es igualmente aceptado, efectivo y seguro que el SO, en niños deshidratados por diarrea. El sabor preferido fue el de manzana y el que se asoció con más vómitos, el de naranja.


Asunto(s)
Humanos , Masculino , Femenino , Preescolar , Adolescente , Diarrea/terapia , Deshidratación , Soluciones para Rehidratación/uso terapéutico , Fluidoterapia , Frutas/uso terapéutico
16.
Eur J Cancer Prev ; 9(6): 395-400, 2000 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11201677

RESUMEN

Lung cancer is one of major public health problems facing the world today, owing to the high incidence of the disease and its poor prognosis. Although the principal cause of lung cancer is tobacco use, smokers find it extremely difficult to quit the habit. Hence, there is a need to take action targeted at other risk factors for this disease. One such factor is diet, which is known to be able to raise or lower the risk of lung cancer. This paper seeks to complement other reviews in the field and to shed more light both on the influence that dietary factors may have upon the occurrence of this neoplasm and on the causes of this possible effect.


Asunto(s)
Dieta , Neoplasias Pulmonares/prevención & control , Ácido Ascórbico/uso terapéutico , Carotenoides/uso terapéutico , Dieta/métodos , Frutas/uso terapéutico , Humanos , Fitoterapia , Factores de Riesgo , Verduras/uso terapéutico
17.
Nutr Metab Cardiovasc Dis ; 10(6): 331-7, 2000 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11302008

RESUMEN

BACKGROUND AND AIM: The health-promoting effects of fruit- and vegetable-based diets are known to be associated with their antioxidative components. We found in our preliminary in vitro laboratory tests that extracts of many common Finnish edible berries are potent scavengers of peroxyl radicals and inhibitors of lipid peroxidation. We therefore designed the current study to evaluate both the long-term (8 weeks) and short-term (5 hours) effects of increased intake of three berries on antioxidant potential and lipid peroxidation. METHODS AND RESULTS: Healthy 60-year-old men were randomized to berry, supplement and control groups (20 men in each group). The berry group ate, in addition to their normal diet, a 100 g portion of deep-frozen berries (bilberries, lingonberries, or black currants) daily for 8 weeks. The other groups ingested daily 100 mg of alpha-tocopherol and 500 mg of ascorbic acid (supplement group) or 500 mg of calcium gluconate (control group). In the short-term experiment 6 men ate 80 g of each of the three berries in one go. Serum ascorbate concentrations increased significantly in both the berry and the supplement group. Serum alpha-tocopherol levels and the antioxidant potential (TRAP) in low density lipoprotein (LDL) increased in the supplement group only. In the berry group, slightly lowered LDL diene conjugation (p = 0.074) and slightly increased total serum TRAP (p = 0.084) values were observed. No changes were found in these measures in the supplement or the control group. In the short-term experiment, LDL TRAP showed a small increase (about 10%, p = 0.039) during five hours after the intake of 240 g berries. CONCLUSIONS: The effects of consumption of berries on antioxidant potential and diene conjugation in LDL particles in vivo appear to be small.


Asunto(s)
Ácido Ascórbico/sangre , Frutas/uso terapéutico , Peroxidación de Lípido , Lipoproteínas LDL/metabolismo , Fitoterapia , Vitamina E/sangre , Antioxidantes/metabolismo , Estudios de Cohortes , Suplementos Dietéticos , Humanos , Masculino , Persona de Mediana Edad , Oxidación-Reducción
18.
Nutr Rev ; 57(9 Pt 2): S3-6, 1999 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10568344

RESUMEN

Several "traditional" nutrients and dietary fiber have been associated with both increased and decreased risk of chronic diseases. However, there are many minor components in foods, particularly plant-derived foods, that elicit biologic responses in mammalian systems that are consistent with reduced risk of one or more chronic diseases (phytonutrients). These phytonutrients have been categorized into ten classes of compounds or biologic activities. Representative compounds, typical biologic activities, and common food sources are tabulated for each phytonutrient class. A brief discussion of each category is presented along with several structure-activity relationships.


Asunto(s)
Alimentos/clasificación , Frutas/metabolismo , Frutas/uso terapéutico , Valor Nutritivo , Fitoterapia , Proteínas de Vegetales Comestibles/metabolismo , Proteínas de Vegetales Comestibles/uso terapéutico , Humanos , Neoplasias/prevención & control
19.
Am J Clin Nutr ; 70(3 Suppl): 475S-490S, 1999 09.
Artículo en Inglés | MEDLINE | ID: mdl-10479220

RESUMEN

Epidemiologic data support the association between high intake of vegetables and fruits and low risk of chronic disease. There are several biologically plausible reasons why consumption of vegetables and fruit might slow or prevent the onset of chronic diseases. Vegetables and fruit are rich sources of a variety of nutrients, including vitamins, trace minerals, and dietary fiber, and many other classes of biologically active compounds. These phytochemicals can have complementary and overlapping mechanisms of action, including modulation of detoxification enzymes, stimulation of the immune system, reduction of platelet aggregation, modulation of cholesterol synthesis and hormone metabolism, reduction of blood pressure, and antioxidant, antibacterial, and antiviral effects. Although these effects have been examined primarily in animal and cell-culture models, experimental dietary studies in humans have also shown the capacity of vegetables and fruit and their constituents to modulate some of these potential disease-preventive mechanisms. The human studies have relied on intermediate endpoints related to disease risk. Design methodologies used include multiple-arm trials, randomized crossover studies, and more compromised designs such as nonrandomized crossovers and pre- and posttreatment analyses. Length of treatment ranged from a single dose to years depending on the mechanism of interest. Stringency of dietary control varied from addition of supplements to a habitual diet to provision of all food for the duration of a treatment. Rigorously conducted experimental dietary studies in humans are an important link between population- and laboratory-based research.


Asunto(s)
Dieta , Frutas/uso terapéutico , Fitoterapia , Verduras/uso terapéutico , Antioxidantes/uso terapéutico , Biomarcadores , Colesterol/metabolismo , Dieta Vegetariana , Métodos Epidemiológicos , Frutas/química , Humanos , Agregación Plaquetaria , Prevención Primaria , Ensayos Clínicos Controlados Aleatorios como Asunto , Verduras/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA